Drugs.com: Effect of cancer treatment on COVID-19 mortality

A UC study sheds light on death rates as they relate to patients with cancer and COVID-19

Cancer patients treated one to three months prior to COVID-19 diagnosis and those treated with chemoimmunotherapy have the highest 30-day mortality, according to a study presented at the annual meeting of the European Society for Medical Oncology, held virtually from Sept. 19 to 21.

Lead author Trisha Wise-Draper, MD, PhD, associate professor of medicine, UC Health oncologist and member of the UC Cancer Center, and colleagues examined outcomes related to systemic cancer treatment within one year of laboratory-confirmed severe acute respiratory syndrome coronavirus 2 infection. 

Read the full Drugs.com/HealthDay News story.

Read the full UC News story.

Featured photo courtesy of the National Cancer Institute.

Next Lives Here

The University of Cincinnati is classified as a Research 1 institution by the Carnegie Commission and is ranked in the National Science Foundation's Top-35 public research universities. UC's graduate students and faculty investigate problems and innovate solutions with real-world impact. Next Lives Here.

Related Stories


Students organize to shake up Parkinson's care model

July 15, 2024

University of Cincinnati student and Parkinson's Together founder Mallika Desai joined the Parkinson's Experience Podcast to discuss the nonprofit's origins and multidisciplinary mission to meet the needs of patients in their community.

Debug Query for this